Connect with us

Health

Cancer trends revealed, including most common types of the disease and biggest risk factors

Published

on

Cancer trends revealed, including most common types of the disease and biggest risk factors

Almost 40% of Americans will receive a cancer diagnosis at some point in their lifetime — but certain types are more common than others, statistics show.

USAFacts, a Washington-based nonprofit that compiles government data and reports on it, took a deep dive into the latest cancer data to identify trends — and shared the results with Fox News Digital.

Of the 1.96 million new cancer cases in 2023, half were made up of five types: breast cancer (15%), prostate cancer (15%), lung and bronchus cancer (12%), colorectal cancers (8%) and all other types (50%).

CANCER CAUSES: THESE 10 HIDDEN CARCINOGENS CAN RAISE THE RISK, ACCORDING TO AN ONCOLOGY EXPERT

Among the 609,820 cancer deaths in 2023, nearly half were made up of lung and bronchus cancer (21%), colorectal cancers (9%), pancreatic cancer (8%) and breast cancer (7%). 

Advertisement

The remaining 55% of deaths were attributed to other cancers.

Almost 40% of Americans will receive a cancer diagnosis at some point in their lifetime — but certain types are more common than others. USAFacts, a Washington-based nonprofit that compiles government data and reports on it, studied the numbers and shared trends with Fox News Digital.  (iStock)

While cancer cases have risen overall due to a growing population, the share of people getting diagnosed and dying from the disease has decreased.

“Between 2000 and 2019, the incidence rate — or the rate of new cancer cases per 100,000 people — declined by 5.4%, while the annual mortality rate fell by more than 26%,” the report stated.

The share of people getting diagnosed and dying from cancer has actually decreased.

Advertisement

“This suggests improvements in cancer prevention, detection and treatment,” Dr. Brett Osborn, a Florida neurologist and longevity expert, told Fox News Digital in a statement.

Osborn was not involved in the report, but commented on the findings.

Here are five standout observations.

1. Gender-specific risk

As of 2019, men were about 15.4% more likely to receive a new cancer diagnosis and 37.5% more likely to die from the disease than women.

That gap has narrowed since 2000, however, when the cancer incidence rate was more than 37% higher for men.

Advertisement

FOODS TO EAT, AND NOT EAT, TO PREVENT CANCER, ACCORDING TO A DOCTOR AND NUTRITIONIST

For men, the most common cancers are prostate, lung and colorectal cancers, the USAFacts report stated. 

Those types made up 50.8% of new cancer cases and 45.9% of cancer deaths in 2023 among males. 

As of 2019, men were about 15.4% more likely to receive a new cancer diagnosis and 37.5% more likely to die from the disease than women. (Centers for Disease Control and Prevention )

Among women, the most prevalent types are breast cancer, lung cancer and colorectal cancer. 

Advertisement

Those three types comprised 54.6% of new cancer cases and 50.1% of cancer deaths in 2023 for females.

2. Cancer rates across ethnic groups

White Americans have the highest rate of new cancer diagnoses, followed by non-Hispanic Black Americans, the report stated.

Among cancer deaths, however, non-Hispanic Black Americans are at the highest risk.

SOME BREAST CANCER PATIENTS COULD BE AT RISK OF ANOTHER TYPE OF CANCER, STUDY REVEALS

Non-Hispanic Asian/Pacific Islander Americans have the lowest risk of diagnosis and mortality. 

Advertisement

Overall cancer incidence rates have dropped between 2000 and 2019 for every group except American Indian/Alaska Native people, who experienced a nearly 35% increase in diagnoses.

White Americans have the highest rate of new cancer diagnoses, followed by non-Hispanic Black Americans, the report stated. (National Cancer Institute)

“While the reason behind these disparities is hard to pin down, contributing factors include access to health care, environmental conditions, lifestyle behaviors and genetics,” the report states.

3. Cancer survival rates

The five-year cancer survival rate has risen, going from 63.5% in 2000 to 68.4% in 2015 — and is expected to continue its upward trend.

“This improvement is credited to better prevention, early detection and advancements in treatment,” according to Osborn.

Advertisement

The five-year cancer survival rate has risen, going from 63.5% in 2000 to 68.4% in 2015, and is expected to continue its upward trend. (National Cancer Institute)

Survival rates vary by cancer type.

The cancers with the highest five-year survival rate are thyroid (98.8%), prostate cancer (96.5%), testicular cancer (95.7%), skin cancer (93.6%) and breast cancer (91.0%).

CANCER RATES RISING IN YOUNG PEOPLE DUE TO ‘ACCELERATED AGING,’ NEW STUDY FINDS: ‘HIGHLY TROUBLING’

“It should be noted that estimated cancer deaths in 2023 do not reflect the five-year survival rate between 2015 and 2020, as deaths in 2023 may result from cancer cases diagnosed prior to the five-year window,” the report stated.

Advertisement

4. Average age of cancer diagnosis

Age is the most prevalent risk factor for a cancer diagnosis, according to the report.

Diagnosis rates rise steadily for each decade of life.

Age is the most prevalent risk factor for a cancer diagnosis, according to the new report. (National Cancer Institute)

The average age of diagnosis is 66 and the average age of death is 72, according to data gathered by the National Cancer Institute (NCI) between 2016 and 2020.

The disease can occur at any age, however — which is why experts recommend early screenings to reduce mortality rates.

Advertisement

5. Importance of guarding against ‘complacency’

Despite the improvements in cancer incidence and mortality rates, Osborn warned that Americans “should not be lulled into complacency.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“According to 2024 data from the American Cancer Society, the incidence of six of the most common cancers – namely those related to excess body weight, such as endometrial, liver, kidney, pancreas, colorectal and breast – are on the rise and may temper the declining mortality rate in the future,” he warned.

Rising obesity rates in the U.S. are a direct cancer driver, Osborn indicated.

While cancer cases have risen overall due to a growing population, the share of people getting diagnosed and dying from the disease has decreased. (National Cancer Institute)

Advertisement

“It is estimated that more than two in five adults (42.4%) have obesity – a gateway disease to cancer — according to recent data from the National Institute of Diabetes and Digestive and Kidney Diseases,” said Osborn. 

“One can only hope that we are not headed in the wrong direction.”

“Unless the tide is turned and the obesity epidemic is addressed, the observed reduction in the annual rate of new cancers and associated mortality will slow and potentially be extinguished,” he continued. 

“One can only hope that we are not headed in the wrong direction.”

Advertisement

USAFacts compiled its report using data from the NCI, the U.S. Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS).

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

‘Weight Loss Has Never Been About Calories’: How This Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs!

Published

on

‘Weight Loss Has Never Been About Calories’: How This Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs!


Advertisement


Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs, No Calorie Counting! | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Weight-loss experts predict 5 major treatment changes likely to emerge in 2026

Published

on

Weight-loss experts predict 5 major treatment changes likely to emerge in 2026

NEWYou can now listen to Fox News articles!

Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods.

Weight-loss experts spoke with Fox News Digital about their predictions for the most major changes to come in 2026.

No. 1: Shift to whole-body treatment 

Dr. Peter Balazs, a hormone and weight loss specialist in New York and New Jersey, shared that the most important shift is likely to label GLP-1 drugs as “multi-system metabolic modulators” rather than “simple weight loss drugs.”

MORE AMERICANS MAY BE CLASSIFIED AS OBESE UNDER NEW DEFINITION, STUDY SUGGESTS

Advertisement

“The treatment goal is no longer just BMI reduction, but total cardiometabolic risk mitigation, with effects now documented across the liver, heart, kidneys and vasculature,” he said.

“We are seeing a significant reduction in major adverse cardiovascular events … and progression of renal disease,” he went on.

The focus of GLP-1 drugs will widen beyond weight loss and diabetes, according to experts’ predictions. (iStock)

Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, also shared that “exciting” advancements lie ahead for weight-loss drugs, including GLP-1s and GIPs.

OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT-LOSS DRUGS FOR 4 KEY REASONS

Advertisement

“These next‑generation agents, along with novel combinations that include glucagon and amylin agonists, are demonstrating even more impressive weight‑loss outcomes than currently available therapies, with the potential for better tolerability and sustained results,” he told Fox News Digital.

“There is also tremendous optimism around new federal agreements with manufacturers that aim to make these medications more widely accessible and affordable for the broad population of patients who need them most.”

No. 2: More convenient dosing

The typical prescription for a GLP-1 medication is a weekly injection, but delivery and dosing may be changing to more convenient methods in 2026, according to Balazs.

OPRAH JOINS WAVE OF CELEBRITIES WHO REVEALED DRAMATIC WEIGHT LOSS IN 2025

A daily 25 mg pill version of Novo Nordisk’s Wegovy, a semaglutide designed to treat obesity, is now approved and available for chronic weight management, offering a non-injectable option for some patients.

Advertisement

A once-weekly oral GLP-1 is currently in phase 2 trials, as well as an implant that aims for three to six months of drug delivery, Balazs noted.

Incisionless weight-loss procedures will rise as a lower-risk option, according to experts. (iStock)

No. 3: Less invasive surgery

In addition to decreased risk during surgery for GLP-1 users, Balazs also predicted that metabolic surgery without incision will rise as a better option.

“Incisionless endoscopic procedures — like endoscopic sleeve gastroplasty (non-surgical weight-loss procedure that makes the stomach smaller from the inside) and duodenal mucosal resurfacing (non-surgical procedure that resets part of the small intestine to help the body better handle blood sugar) — [may become] more durable and widely available,” he said. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“These offer significant metabolic benefits with shorter recovery and lower risk than traditional surgery.”

Rabito agreed that “rapid progress” in minimally invasive weight‑loss procedures is “opening powerful new options for patients who are hesitant to pursue traditional bariatric surgery.”

Bariatric surgery remains the most effective weight loss method, one specialist says. (iStock)

This avenue offers “meaningful and durable weight reduction with less risk, shorter recovery times and no external incisions,” the expert added.

Dr. Muhammad Ghanem, bariatric surgeon at the Orlando Health Weight Loss & Bariatric Surgery Institute, reiterated that surgery remains “the most successful modality for the treatment of obesity … with the highest weight loss and most durable outcomes as of yet.”

Advertisement

No. 4: Younger GLP-1 users

As Novo Nordisk’s Wegovy has been indicated for adolescents over 12 years old as an obesity treatment, Balazs commented that pediatric use of weight-loss drugs is “now a clinical reality.”

He predicted that other alternatives are likely to be approved in 2026 for younger users.

No. 5: High-tech, personalized access

Amid the growth of artificial intelligence, Balazs predicted an expansion in the clinical implementation of AI-driven weight-loss methods.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

This could include categorizing obesity into sub-types like “hungry brain,” “emotional hunger” and “slow burn” to personalize how therapy is prescribed while moving away from “trial and error,” he said.

Advertisement

Ghanem agreed that there will likely be a “big focus” on individualized testing for causes of obesity in 2026, as it’s a disease that can have “different causes in different people,” thus requiring different treatments.

AI and other digital opportunities will drive more access for weight-loss patients, experts say. (iStock)

The doctor anticipates that more patients will seek combinations of comprehensive treatments and programs.

“Patients are more aware that now we have a few weapons in our arsenal to combat obesity, and [they] are seeking a multidisciplinary and holistic approach,” Ghanem said.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Treatment options will also turn digital with the rise of prescription digital therapeutics (PDTs) for weight loss, Balazs predicted.

“These are software applications delivering cognitive behavioral therapy, personalized nutrition and metabolic coaching through algorithms, often integrated with continuous glucose monitors, and reimbursed as medical treatments,” he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Ghanem added that body composition analyzers, like DEXA scans, will likely be more widely used as awareness grows about the limitations of BMI and weight in assessing obesity.

Advertisement
Continue Reading

Health

Brain Health Challenge: Doctor Appointments for Your Mind and Body

Published

on

Brain Health Challenge: Doctor Appointments for Your Mind and Body

Congratulations, you’ve reached the final day of the Brain Health Challenge! Today, we’re asking you to do a few things that might feel a bit out of left field — like getting your blood pressure checked.

No, it isn’t as fun as playing Pips, but experts say it’s one of the most important things you can do for your brain. That’s because heart health and brain health are intrinsically linked.

Advertisement

High blood pressure, in particular, can damage brain cells, and it’s a significant risk factor for stroke and dementia. When blood pressure is too high, it places stress on the walls of arteries in the brain. Over time, that added stress can cause the blood vessel walls to thicken, obstructing blood flow. In other cases, the increased pressure causes the artery walls to thin and leak blood into the brain.

These changes to the blood vessels can sometimes cause a large stroke to occur. More commonly, the damage leads to micro-strokes and micro-hemorrhages, which cause fewer immediate problems and often go unnoticed. But if someone has hypertension for years or decades, these injuries can build up, and the person may start to experience cognitive impairment.

Advertisement

High blood pressure “is known as a silent killer for lots of reasons,” said Dr. Shyam Prabhakaran, the chair of neurology at the University of Chicago. “It doesn’t cause you any symptoms until it does.”

Because the damage accumulates over many years, experts say that managing blood pressure in midlife matters most for brain health. Hypertension can be addressed with medication or lifestyle changes, as directed by your doctor. But the first thing you need to do is know your numbers. If your blood pressure comes back higher than 120/80, it’s important to take it seriously, Dr. Prabhakaran said.

While you’re at it, there are a few other aspects of your physical health that you should check on.

Advertisement

Your eyes and ears are two of them. Hearing and vision loss have both been shown to increase the risk of dementia. Experts think that with less sensory information coming in to stimulate the brain, the regions that process hearing and vision can start to atrophy. What’s more, people with sensory loss often withdraw or are left out of social interactions, further depriving them of cognitive stimulation.

Oral health can also affect your brain health. Research has found a connection between regular flossing and reduced odds of having a stroke. That may be because good oral health can help to reduce inflammation in the body. The bacteria that cause gum disease have also been tied to an increased risk of Alzheimer’s.

Advertisement

And have you gotten your shingles vaccine? There is mounting evidence that it’s a powerful weapon for protecting against dementia. One study found that it lowered people’s odds of developing the condition by as much as 20 percent.

To wrap up this challenge, we want you to schedule a few medical appointments that benefit your brain, as well as your body.

After five days of feeding, exercising and challenging your brain, you are well on your way to better cognitive health. Thanks for joining me this week, and keep up the good habits!

Advertisement

Continue Reading

Trending